Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known Arnar B. IngasonJohann P. HreinssonEinar S. Björnsson Review Article 13 October 2022 Pages: 1449 - 1456
Prevalence, Causes and Severity of Medication Administration Errors in the Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis Josephine Henry BasilChandini Menon PremakumarNoraida Mohamed Shah Systematic Review 03 October 2022 Pages: 1457 - 1476
mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study Eric Yuk Fai WanCeline Sze Ling ChuiIan Chi Kei Wong Original Research Article 02 October 2022 Pages: 1477 - 1490
Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies Giulio BarteselliGrant R. GoodmanSamuel McCallum Original Research Article Open access 30 October 2022 Pages: 1491 - 1499
Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission Bastiaan T. G. M. SalleveltToine C. G. EgbertsWilma Knol Original Research Article Open access 01 November 2022 Pages: 1501 - 1516
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing Amir SarayaniChristian HamppAlmut G. Winterstein Original Research Article 01 November 2022 Pages: 1517 - 1527
Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard Shaun M. ComfortBruce DonzantiFrancis Donaldson Original Research Article 23 October 2022 Pages: 1529 - 1538
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database Chiara GastaldonGeorgios SchoretsanitisCorrado Barbui Original Research Article Open access 18 November 2022 Pages: 1539 - 1549
Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)" Yoshihiro Noguchi Letter to the Editor 12 October 2022 Pages: 1551 - 1552
Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)” Daniel C. MaloneLorenzo Villa-ZapataRichard D. Boyce Letter to the Editor 12 October 2022 Pages: 1553 - 1555